5,309
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Preventing chronic obstructive pulmonary disease

Pages 449-452 | Published online: 09 Jan 2014

References

  • Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med.176(6), 532–555 (2007).
  • Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J.23(6), 932–946 (2004).
  • Guindon G, Boisclair D. Past, Current, and Future Trends in Tobacco Use. The World Bank, DC, USA (2003).
  • Forey B, Hamling J, Lee P, Wald N. International Smoking Statistics: A Collection of Historical Data from 30 Economically Developed countries (2nd Edition). Oxford University Press, London, UK (2002).
  • Global Youth Tabacco Survey Collaborative Group. Tobacco use among youth: a cross country comparison. Tob. Control11(3), 252–270 (2002).
  • Swedish Council for Information on Alcohol and Other Drugs. The 1999 ESPAD Report. Vol. 2003. The Swedish Council for Information on Alcohol and Other Drugs, Stockholm, Sweden (2000).
  • Chapman KR. Chronic obstructive pulmonary disease: are women more susceptible than men? Clin. Chest Med.25(2), 331–341 (2004).
  • Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur. Respir. J.28(3), 523–532 (2006).
  • Lader D. Smoking-related Behaviour and Attitudes, 2006. Office for National Statistics, Newport, UK (2007).
  • Stapleton J. Cigarette smoking prevalence, cessation and relapse. Stat. Methods Med. Res.7, 187–203 (1998).
  • Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ309(6959), 901–911 (1994).
  • Jha P, Chaloupka F. Curbing the Epidemic: Governments and the Economics of Tobacco Control. The World Bank, DC, USA (1999).
  • Hu T-W, Sung H-Y, Keeler T. Reducing cigarette consumption in California: tobacco taxes vs. an antismoking media campaign Am. J. Public Health85(9), 1218–1222 (1995).
  • Townsend J, Roderick P, Cooper J. Cigarette smoking by socioeconomic group, sex, and age: effects of price, income, and health publicity. BMJ309, 923–927 (1994).
  • Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev.1, CD000146 (2008).
  • Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst. Rev.1, CD000031 (2007).
  • Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst. Rev.3, CD006103 (2008).
  • Goodman N, Lane R, Rampling S. Chronic bronchitis: an introductory examination of exisiting data. BMJ4830, 237–243 (1953).
  • Becklake M, Dupreez L, Lutz W. Lung function in silicosis of the Witwatersrand gold miner. Am. Rev. Tuberc. Pulm. Dis.77, 400–412 (1958).
  • Becklake MR. Chronic airflow limitation: its relationship to work in dusty occupations. Chest88(4), 608–617 (1985).
  • Blanc PD, Iribarren C, Trupin L et al. Occupational exposures and the risk of COPD: dusty trades revisited. Thorax64(1), 6–12 (2009).
  • Harber P, Tashkin DP, Simmons M, Crawford L, Hnizdo E, Connett J. Effect of occupational exposures on decline of lung function in early chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.176(10), 994–1000 (2007).
  • US Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Department of Health and Human Services, Atlanta, GA, USA (2006).
  • Gold D, Wang X, Wypij D, Spizer F, Ware J, Dockery D. Effects of cigarette smoking on the pulmonary function in adolescent boys and girls. N. Engl. J. Med.335, 931–937 (1996).
  • Skogstad M, Kjaerheim K, Fladseth G et al. Cross shift changes in lung function among bar and restaurant workers before and after implementation of a smoking ban. Occup. Environ. Med.63(7), 482–487 (2006).
  • Eisner MD, Balmes J, Katz PP, Trupin L, Yelin EH, Blanc PD. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ. Health4(1), 7 (2005).
  • Eisner MD. Secondhand smoke and obstructive lung disease: a causal effect? Am. J. Respir. Crit. Care Med.179(11), 973–974 (2009).
  • Goodman P, Agnew M, McCaffrey M, Paul G, Clancy L. Effects of the Irish smoking ban on respiratory health of bar workers and air quality in Dublin pubs. Am. J. Respir. Crit. Care Med.175(8), 840–845 (2007).
  • Dennis R, Maldonado D, Norman S et al. Wood smoke exposure and risk for obstructive airways disease among women. Chest109(1), 115–119 (1996).
  • Behera D, Jindal S. Respiratory symptoms in Indian women using domestic cooking fuels. Chest100, 385–388 (1991).
  • Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors: systematic analysis of population health data. Lancet367(9524), 1747–1757 (2006) (2001).
  • Torres-Duque C, Maldonado D, Perez-Padilla R, Ezzati M, Viegi G. Biomass fuels and respiratory diseases: a review of the evidence. Proc. Am. Thorac. Soc.5, 577–590 (2008).
  • Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet370(9589), 765–773 (2007).
  • Anto JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur. Respir. J.17(5), 982–994 (2001).
  • Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ303, 671–675 (1991).
  • Shaheen S, Barker D, Holgate S. Do lower respiratory tract infections in early childhoo cause chronic obstructive pulmonary disease? Am. J. Respir. Crit. Care Med.151, 1649–1652 (1995).
  • Lawlor D, Ebrahim S, Davey Smith G. Association of birth weight with adult lung function: findings from the British Women’s Heart and Health Study and a meta-analysis. Thorax60, 851–858 (2005).
  • Halpin DMG, Fehrenbach C, Bellamy D, Rudolf M. What does the general public know about COPD ? Thorax57(Suppl. 3), iii45 (2002).
  • Weinman J, Yusuf G, Berks R, Rayner S, Petrie KJ. How accurate is patients’ anatomical knowledge: a cross-sectional, questionnaire study of six patient groups and a general public sample. BMC Fam. Pract.10, 43 (2009).
  • Seamark DA, Williams S, Timon S et al. Home or surgery based screening for chronic obstructive pulmonary disease (COPD)? Prim. Care Respir. J.10(2), 30–33 (2001).
  • Van Schayck CP, Loozen JM, Wagena E, Akkermans RP, Wesseling GJ. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ324(7350), 1370 (2002).
  • Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med.148, 535–543 (2008).
  • Shahab L, Jarvis MJ, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax61(12), 1043–1047 (2006).
  • Bize R, Burnand B, Mueller Y, Rege Walther M, Cornuz J. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst. Rev.2, CD004705 (2009).
  • Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax57(10), 847–852 (2002).
  • Celli BR, Thomas NE, Anderson JA et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am. J. Respir. Crit. Care Med.178(4), 332–338 (2008).
  • Tashkin D, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med.359, 1543–1554 (2008).
  • Decramer M, Rennard S, Troosters T et al. COPD as a lung disease with systemic consequences – clinical impact, mechanisms, and potential for early intervention. COPD5(4), 235–256 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.